The enormous diversity of HIV creates something of a moving target for researchers as emerging strains become more virulent and resistant to therapy.
Internal medicine and emergency medicine physicians fail to offer HIV testing at sufficient levels.
With the continuous increasing epidemic of multidrug-resistant TB, new drugs and vaccines are urgently needed.
There is an imminent need for greater understanding of food allergies, revised diagnostics and development of safe, effective therapies. Is oral immunotherapy the answer?
During these hard economic times when unemployment is at an all-time high, a nursing career offers thousands of jobs all over the world. But is a nursing career an option for an HIV-positive person? The answer to that question is yes.
Learn about the clinical significance of the influenza virus infection and vaccine safety in HIV infected individuals, solid-organ and stem-cell transplant recipients and patients receiving biological agents.
Did the women in this study report feelings of regret once they disclosed their HIV serostatus? Did the social and sexual network members influence the likelihood of experiencing regret?
Type 1 diabetes is an autoimmune disease, but how well do patients with T1DM respond to treatment with antibodies - and when should they be introduced?
HIV is a difficult virus to treat and no vaccine has been developed. One approach is to combine two or three treatments to form a cocktail of drugs that have a greater chance of slowing the spread of HIV around the body and the subsequent deterioration of the patient. This is known as highly active
Drs. Douglas Shaffer and Eunice Obiero highlight some of the key lessons learned from their experience with an integrated HIV/TB clinic in Kenya.
What are the patient risk factors for failure to follow-up in HIV care?
Dolutegravir (DTG) is a newer, potent INI. How effective and tolerable is it in treatment-naïve HIV patients?
Paul E. Sax, MD provides a review of a highly anticipated study at AIDS 2010. Learn about the efficacy and tolerability of the investigational NNRT rilpivirine (TMC-278) as compared with efavirenz.
If you or someone close to you has AIDS, there are medical treatments that are surely being sought to slow the progress of the disease and address the health issues that come as a result of infection. There are other, alternative remedies that those who have AIDS use to better their quality of life.
Despite recommendations for routine HIV testing in health care settings, many remain untested.
This review focuses on how HIV alters the clinical presentation of malaria, what effect it may have on the natural history of HIV, and interaction for surveillance systems, burden estimates and for the prediction of future trends.
AIDS Medical Training Facility to Open in Uganda... Funding Available for Treatment Adherence Research...
HIV clinicians in the developing world have yet another challenge: screening out counterfeit antiretrovirals.